Phase II trial of the IDO pathway inhibitor indoximod plus pembrolizumab for the treatment of patients with advanced melanoma
=============================================================================================================================

* Yousef Zakharia
* Robert R McWilliams
* Olivier Rixe
* Joseph Drabick
* Montaser F Shaheen
* Kenneth F Grossmann
* Ravindra Kolhe
* Rafal Pacholczyk
* Ramses Sadek
* Lucinda L Tennant
* Christopher M Smith
* Eugene P Kennedy
* Charles J Link Jr
* Nicholas N Vahanian
* Jiayi Yu
* Steven S Shen
* Erik L Brincks
* Gabriela R Rossi
* David Munn
* Mohammed Milhem